- HC Wainwright 22nd Annual
Global Investor Conference: The Company will present at 12:00 noon on Tuesday, September 15, 2020.
- Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit: The Company will present at
4.10 pmon Wednesday, September 23, 2020
- Jefferies IBD Therapeutics Summit: The Company will present at a time to be determined on
Wednesday, September 23, 2020.
These are virtual events. A live webcast of the presentations can be accessed under “Event Calendar” in the Investors & Media section of the Company’s website. An archived copy of the webcast will be available on the
Synlogic™ is bringing the transformative potential of synthetic biology to medicine. With a premiere synthetic biology platform that leverages a reproducible, modular approach to microbial engineering,
This press release contains “forward-looking statements” that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations, clinical development plans, future financial position, future revenue, projected expenses, prospects, plans and objectives of management are forward-looking statements. In addition, when or if used in this press release, the words “may,” “could,” “should,” “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “predict” and similar expressions and their variants, as they relate to